Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShort-Term Debt repayments
Ratios

Xtant Medical Holdings (XTNT) Short-Term Debt repayments (2017 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Short-Term Debt repayments for 6 consecutive years, with $26.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Short-Term Debt repayments rose 2.71% to $26.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $105.5 million, a 5.16% increase, with the full-year FY2024 number at $105.1 million, up 36.59% from a year prior.
  • Short-Term Debt repayments was $26.5 million for Q3 2025 at Xtant Medical Holdings, up from $25.9 million in the prior quarter.
  • In the past five years, Short-Term Debt repayments ranged from a high of $27.5 million in Q2 2024 to a low of $12.3 million in Q1 2022.
  • A 5-year average of $20.1 million and a median of $20.1 million in 2023 define the central range for Short-Term Debt repayments.
  • Peak YoY movement for Short-Term Debt repayments: fell 6.36% in 2022, then surged 55.04% in 2024.
  • Xtant Medical Holdings' Short-Term Debt repayments stood at $13.5 million in 2021, then grew by 10.6% to $14.9 million in 2022, then surged by 49.44% to $22.3 million in 2023, then grew by 21.75% to $27.1 million in 2024, then dropped by 2.33% to $26.5 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Short-Term Debt repayments are $26.5 million (Q3 2025), $25.9 million (Q2 2025), and $26.0 million (Q1 2025).